Regulation of RelA subcellular localization by a putative nuclear export signal and p50
- PMID: 10490645
- PMCID: PMC84703
- DOI: 10.1128/MCB.19.10.7088
Regulation of RelA subcellular localization by a putative nuclear export signal and p50
Abstract
Nuclear factor kappaB (NF-kappaB) represents a family of dimeric DNA binding proteins, the pleotropic form of which is a heterodimer composed of RelA and p50 subunits. The biological activity of NF-kappaB is controlled through its subcellular localization. Inactive NF-kappaB is sequestered in the cytoplasm by physical interaction with an inhibitor, IkappaBalpha. Signal-mediated IkappaBalpha degradation triggers the release and subsequent nuclear translocation of NF-kappaB. It remains unknown whether the NF-kappaB shuttling between the cytoplasm and nucleus is subjected to additional steps of regulation. In this study, we demonstrated that the RelA subunit of NF-kappaB exhibits strong cytoplasmic localization activity even in the absence of IkappaBalpha inhibition. The cytoplasmic distribution of RelA is largely mediated by a leucine-rich sequence homologous to the recently characterized nuclear export signal (NES). This putative NES is both required and sufficient to mediate cytoplasmic localization of RelA as well as that of heterologous proteins. Furthermore, the cytoplasmic distribution of RelA is sensitive to a nuclear export inhibitor, leptomycin B, suggesting that RelA undergoes continuous nuclear export. Interestingly, expression of p50 prevents the cytoplasmic expression of RelA, leading to the nuclear accumulation of both RelA and p50. Together, these results suggest that the nuclear and cytoplasmic shuttling of RelA is regulated by both an intrinsic NES-like sequence and the p50 subunit of NF-kappaB.
Figures
Similar articles
-
A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1014-9. doi: 10.1073/pnas.97.3.1014. Proc Natl Acad Sci U S A. 2000. PMID: 10655476 Free PMC article.
-
An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha.EMBO J. 1999 Dec 1;18(23):6682-93. doi: 10.1093/emboj/18.23.6682. EMBO J. 1999. PMID: 10581242 Free PMC article.
-
Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export.Cell Res. 2007 Dec;17(12):1020-9. doi: 10.1038/cr.2007.99. Cell Res. 2007. PMID: 18040287
-
Multiple redox regulation in NF-kappaB transcription factor activation.Biol Chem. 1997 Nov;378(11):1237-45. Biol Chem. 1997. PMID: 9426183 Review.
-
Regulation of NF-kappaB action by reversible acetylation.Novartis Found Symp. 2004;259:208-17; discussion 218-25. Novartis Found Symp. 2004. PMID: 15171256 Review.
Cited by
-
IκBα Nuclear Export Enables 4-1BB-Induced cRel Activation and IL-2 Production to Promote CD8 T Cell Immunity.J Immunol. 2020 Sep 15;205(6):1540-1553. doi: 10.4049/jimmunol.2000039. Epub 2020 Aug 14. J Immunol. 2020. PMID: 32817348 Free PMC article.
-
Sustained oscillations of NF-kappaB produce distinct genome scanning and gene expression profiles.PLoS One. 2009 Sep 29;4(9):e7163. doi: 10.1371/journal.pone.0007163. PLoS One. 2009. PMID: 19787057 Free PMC article.
-
IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways.Mol Biol Cell. 2003 Feb;14(2):491-502. doi: 10.1091/mbc.e02-07-0404. Mol Biol Cell. 2003. PMID: 12589049 Free PMC article.
-
Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors.Cancer Res. 2017 Oct 15;77(20):5614-5627. doi: 10.1158/0008-5472.CAN-17-1323. Epub 2017 Aug 17. Cancer Res. 2017. PMID: 28819023 Free PMC article.
-
Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes.Mol Cell Biol. 2000 Nov;20(22):8489-98. doi: 10.1128/MCB.20.22.8489-8498.2000. Mol Cell Biol. 2000. PMID: 11046145 Free PMC article.
References
-
- Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay R T, Virelizier J-L, Dargemont C. Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm. J Cell Sci. 1997;110:369–378. - PubMed
-
- Baeuerle P, Baichwal V R. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 1997;65:111–137. - PubMed
-
- Baeuerle P A. IκB-NF-κB structures: at the interface of inflammation control. Cell. 1998;95:729–731. - PubMed
-
- Baeuerle P A, Baltimore D. A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev. 1989;3:1689–1698. - PubMed
-
- Baldwin A S., Jr The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–683. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials